APO Research, Inc.

APO RESEARCH · REPORT

Pediculosis and Pthiriasis (Lice Infestation) Treatment

Selected research

Market Analysis & Forecast

Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Analysis and Forecast 2026-2032

Market perspective

The global Pediculosis and Pthiriasis (Lice Infestation) Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pediculosis and Pthiriasis (Lice Infestation) Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pediculosis and Pthiriasis (Lice Infestation) Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pediculosis and Pthiriasis (Lice Infestation) Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pediculosis and Pthiriasis (Lice Infestation) Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pediculosis and Pthiriasis (Lice Infestation) Treatment include Actavis, Arborpharma, Logic Products, Major Pharmaceuticals, Omega Pharma, ParaPRO, Perrigo, Prestige Brands and Reckitt Benckier, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pediculosis and Pthiriasis (Lice Infestation) Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pediculosis and Pthiriasis (Lice Infestation) Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Pediculosis and Pthiriasis (Lice Infestation) Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pediculosis and Pthiriasis (Lice Infestation) Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pediculosis and Pthiriasis (Lice Infestation) Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pediculosis and Pthiriasis (Lice Infestation) Treatment revenue, projected growth trends, production technology, application and end-user industry.

Pediculosis and Pthiriasis (Lice Infestation) Treatment Segment by Company

Actavis

Arborpharma

Logic Products

Major Pharmaceuticals

Omega Pharma

ParaPRO

Perrigo

Prestige Brands

Reckitt Benckier

Shionogi

TecLabs

Thornton and Ross

Tianren

Tyratech

Bayer

Pediculosis and Pthiriasis (Lice Infestation) Treatment Segment by Type

Lotion

Shampoo

Creams

Other

Pediculosis and Pthiriasis (Lice Infestation) Treatment Segment by Application

Children

Adult

Pediculosis and Pthiriasis (Lice Infestation) Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediculosis and Pthiriasis (Lice Infestation) Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pediculosis and Pthiriasis (Lice Infestation) Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediculosis and Pthiriasis (Lice Infestation) Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pediculosis and Pthiriasis (Lice Infestation) Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pediculosis and Pthiriasis (Lice Infestation) Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pediculosis and Pthiriasis (Lice Infestation) Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Lotion Major Player Table 3. Shampoo Major Player Table 4. Creams Major Player Table 5. Other Major Player Table 6. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Children Major Player Table 8. Adult Major Player Table 9. Pediculosis and Pthiriasis (Lice Infestation) Treatment Industry Trends Table 10. Pediculosis and Pthiriasis (Lice Infestation) Treatment Industry Drivers Table 11. Pediculosis and Pthiriasis (Lice Infestation) Treatment Industry Opportunities and Challenges Table 12. Pediculosis and Pthiriasis (Lice Infestation) Treatment Industry Restraints Table 13. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Share by Region (2021-2026) Table 16. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Share by Region (2027-2032) Table 18. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Market Share by Players (2021-2026) Table 20. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Key Players Headquarters & Area Served Table 22. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Players, Product Type & Application Table 23. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Market Share by Type (2021-2026) Table 30. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Market Share by Type (2027-2032) Table 31. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Market Share by Application (2021-2026) Table 35. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Market Share by Application (2027-2032) Table 36. Actavis Company Information Table 37. Actavis Business Overview Table 38. Actavis Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Actavis Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 40. Actavis Recent Development Table 41. Arborpharma Company Information Table 42. Arborpharma Business Overview Table 43. Arborpharma Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Arborpharma Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 45. Arborpharma Recent Development Table 46. Logic Products Company Information Table 47. Logic Products Business Overview Table 48. Logic Products Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Logic Products Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 50. Logic Products Recent Development Table 51. Major Pharmaceuticals Company Information Table 52. Major Pharmaceuticals Business Overview Table 53. Major Pharmaceuticals Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Major Pharmaceuticals Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 55. Major Pharmaceuticals Recent Development Table 56. Omega Pharma Company Information Table 57. Omega Pharma Business Overview Table 58. Omega Pharma Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Omega Pharma Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 60. Omega Pharma Recent Development Table 61. ParaPRO Company Information Table 62. ParaPRO Business Overview Table 63. ParaPRO Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. ParaPRO Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 65. ParaPRO Recent Development Table 66. Perrigo Company Information Table 67. Perrigo Business Overview Table 68. Perrigo Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Perrigo Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 70. Perrigo Recent Development Table 71. Prestige Brands Company Information Table 72. Prestige Brands Business Overview Table 73. Prestige Brands Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Prestige Brands Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 75. Prestige Brands Recent Development Table 76. Reckitt Benckier Company Information Table 77. Reckitt Benckier Business Overview Table 78. Reckitt Benckier Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Reckitt Benckier Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 80. Reckitt Benckier Recent Development Table 81. Shionogi Company Information Table 82. Shionogi Business Overview Table 83. Shionogi Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Shionogi Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 85. Shionogi Recent Development Table 86. TecLabs Company Information Table 87. TecLabs Business Overview Table 88. TecLabs Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. TecLabs Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 90. TecLabs Recent Development Table 91. Thornton and Ross Company Information Table 92. Thornton and Ross Business Overview Table 93. Thornton and Ross Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Thornton and Ross Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 95. Thornton and Ross Recent Development Table 96. Tianren Company Information Table 97. Tianren Business Overview Table 98. Tianren Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Tianren Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 100. Tianren Recent Development Table 101. Tyratech Company Information Table 102. Tyratech Business Overview Table 103. Tyratech Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Tyratech Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 105. Tyratech Recent Development Table 106. Bayer Company Information Table 107. Bayer Business Overview Table 108. Bayer Pediculosis and Pthiriasis (Lice Infestation) Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Bayer Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio Table 110. Bayer Recent Development Table 111. North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2021-2026) & (US$ Million) Table 112. North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2027-2032) & (US$ Million) Table 113. North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (2021-2026) & (US$ Million) Table 117. North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (US$ Million) & (2027-2032) Table 118. Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (2021-2026) & (US$ Million) Table 124. Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (US$ Million) & (2027-2032) Table 125. China Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2021-2026) & (US$ Million) Table 126. China Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2027-2032) & (US$ Million) Table 127. China Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2021-2026) & (US$ Million) Table 128. China Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2021-2026) & (US$ Million) Table 130. Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2027-2032) & (US$ Million) Table 131. Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2021-2026) & (US$ Million) Table 132. Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Region (US$ Million) & (2021-2026) Table 135. Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Region (US$ Million) & (2027-2032) Table 136. SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2021-2026) & (US$ Million) Table 137. SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2027-2032) & (US$ Million) Table 138. SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2021-2026) & (US$ Million) Table 139. SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2027-2032) & (US$ Million) Table 140. SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (2021-2026) & (US$ Million) Table 142. SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (US$ Million) & (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Pediculosis and Pthiriasis (Lice Infestation) Treatment Image Figure 2. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Lotion Image Figure 5. Shampoo Image Figure 6. Creams Image Figure 7. Other Image Figure 8. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 10. Children Image Figure 11. Adult Image Figure 12. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size (US$ Million) & (2021-2032) Figure 13. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Market Share by Type (2021-2032) Figure 20. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Market Share by Application (2021-2032) Figure 23. North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Type (2021-2032) Figure 25. North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Application (2021-2032) Figure 26. North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Country (2021-2032) Figure 27. United States Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Type (2021-2032) Figure 32. Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Application (2021-2032) Figure 33. Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Country (2021-2032) Figure 34. Germany Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Type (2021-2032) Figure 44. China Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Application (2021-2032) Figure 45. Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Type (2021-2032) Figure 47. Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Application (2021-2032) Figure 48. Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Region (2021-2032) Figure 49. Japan Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Type (2021-2032) Figure 57. SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Application (2021-2032) Figure 58. SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Country (2021-2032) Figure 59. Brazil Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Lotion
  • Shampoo
  • Creams
  • Other
Applications
  • Children
  • Adult
Companies covered
  • Actavis
  • Arborpharma
  • Logic Products
  • Major Pharmaceuticals
  • Omega Pharma
  • ParaPRO
  • Perrigo
  • Prestige Brands
  • Reckitt Benckier
  • Shionogi
  • TecLabs
  • Thornton and Ross
  • Tianren
  • Tyratech
  • Bayer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pediculosis and Pthiriasis (Lice Infestation) Treatment Market by Type
  3. 1.2.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Lotion
  5. 1.2.3 Shampoo
  6. 1.2.4 Creams
  7. 1.2.5 Other
  8. 1.3 Pediculosis and Pthiriasis (Lice Infestation) Treatment Market by Application
  9. 1.3.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Children
  11. 1.3.3 Adult
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Dynamics
  1. 2.1 Pediculosis and Pthiriasis (Lice Infestation) Treatment Industry Trends
  2. 2.2 Pediculosis and Pthiriasis (Lice Infestation) Treatment Industry Drivers
  3. 2.3 Pediculosis and Pthiriasis (Lice Infestation) Treatment Industry Opportunities and Challenges
  4. 2.4 Pediculosis and Pthiriasis (Lice Infestation) Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Perspective (2021-2032)
  2. 3.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Growth Trends by Region
  3. 3.2.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Players
  2. 4.1.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Players, Product Type & Application
  8. 4.5 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Market CR5 and HHI
  11. 4.6.3 2025 Pediculosis and Pthiriasis (Lice Infestation) Treatment Tier 1, Tier 2, and Tier 3
5 Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size by Type
  1. 5.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Market Share by Type (2021-2032)
6 Pediculosis and Pthiriasis (Lice Infestation) Treatment Market Size by Application
  1. 6.1 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Actavis
  2. 7.1.1 Actavis Company Information
  3. 7.1.2 Actavis Business Overview
  4. 7.1.3 Actavis Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Actavis Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  6. 7.1.5 Actavis Recent Developments
  7. 7.2 Arborpharma
  8. 7.2.1 Arborpharma Company Information
  9. 7.2.2 Arborpharma Business Overview
  10. 7.2.3 Arborpharma Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Arborpharma Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  12. 7.2.5 Arborpharma Recent Developments
  13. 7.3 Logic Products
  14. 7.3.1 Logic Products Company Information
  15. 7.3.2 Logic Products Business Overview
  16. 7.3.3 Logic Products Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Logic Products Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  18. 7.3.5 Logic Products Recent Developments
  19. 7.4 Major Pharmaceuticals
  20. 7.4.1 Major Pharmaceuticals Company Information
  21. 7.4.2 Major Pharmaceuticals Business Overview
  22. 7.4.3 Major Pharmaceuticals Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Major Pharmaceuticals Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  24. 7.4.5 Major Pharmaceuticals Recent Developments
  25. 7.5 Omega Pharma
  26. 7.5.1 Omega Pharma Company Information
  27. 7.5.2 Omega Pharma Business Overview
  28. 7.5.3 Omega Pharma Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Omega Pharma Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  30. 7.5.5 Omega Pharma Recent Developments
  31. 7.6 ParaPRO
  32. 7.6.1 ParaPRO Company Information
  33. 7.6.2 ParaPRO Business Overview
  34. 7.6.3 ParaPRO Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 ParaPRO Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  36. 7.6.5 ParaPRO Recent Developments
  37. 7.7 Perrigo
  38. 7.7.1 Perrigo Company Information
  39. 7.7.2 Perrigo Business Overview
  40. 7.7.3 Perrigo Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Perrigo Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  42. 7.7.5 Perrigo Recent Developments
  43. 7.8 Prestige Brands
  44. 7.8.1 Prestige Brands Company Information
  45. 7.8.2 Prestige Brands Business Overview
  46. 7.8.3 Prestige Brands Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Prestige Brands Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  48. 7.8.5 Prestige Brands Recent Developments
  49. 7.9 Reckitt Benckier
  50. 7.9.1 Reckitt Benckier Company Information
  51. 7.9.2 Reckitt Benckier Business Overview
  52. 7.9.3 Reckitt Benckier Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Reckitt Benckier Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  54. 7.9.5 Reckitt Benckier Recent Developments
  55. 7.10 Shionogi
  56. 7.10.1 Shionogi Company Information
  57. 7.10.2 Shionogi Business Overview
  58. 7.10.3 Shionogi Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Shionogi Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  60. 7.10.5 Shionogi Recent Developments
  61. 7.11 TecLabs
  62. 7.11.1 TecLabs Company Information
  63. 7.11.2 TecLabs Business Overview
  64. 7.11.3 TecLabs Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  65. 7.11.4 TecLabs Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  66. 7.11.5 TecLabs Recent Developments
  67. 7.12 Thornton and Ross
  68. 7.12.1 Thornton and Ross Company Information
  69. 7.12.2 Thornton and Ross Business Overview
  70. 7.12.3 Thornton and Ross Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Thornton and Ross Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  72. 7.12.5 Thornton and Ross Recent Developments
  73. 7.13 Tianren
  74. 7.13.1 Tianren Company Information
  75. 7.13.2 Tianren Business Overview
  76. 7.13.3 Tianren Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Tianren Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  78. 7.13.5 Tianren Recent Developments
  79. 7.14 Tyratech
  80. 7.14.1 Tyratech Company Information
  81. 7.14.2 Tyratech Business Overview
  82. 7.14.3 Tyratech Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Tyratech Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  84. 7.14.5 Tyratech Recent Developments
  85. 7.15 Bayer
  86. 7.15.1 Bayer Company Information
  87. 7.15.2 Bayer Business Overview
  88. 7.15.3 Bayer Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Bayer Pediculosis and Pthiriasis (Lice Infestation) Treatment Product Portfolio
  90. 7.15.5 Bayer Recent Developments
8 North America
  1. 8.1 North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue (2021-2032)
  2. 8.2 North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country
  11. 8.6.1 North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue (2021-2032)
  2. 9.2 Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country
  11. 9.6.1 Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue (2021-2032)
  2. 10.2 China Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2027-2032)
  5. 10.3 China Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2027-2032)
  9. 10.5 China Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue (2021-2032)
  2. 11.2 Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country
  11. 11.6.1 Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country
  11. 12.6.1 SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pediculosis and Pthiriasis (Lice Infestation) Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.